Tricuspid stenosis pathophysiology

Revision as of 04:46, 2 April 2020 by Gunnam (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Tricuspid stenosis Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Tricuspid stenosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Tricuspid stenosis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tricuspid stenosis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tricuspid stenosis pathophysiology

CDC on Tricuspid stenosis pathophysiology

Tricuspid stenosis pathophysiology in the news

Blogs on Tricuspid stenosis pathophysiology

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Tricuspid stenosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohammed Salih, M.D. Syed Musadiq Ali M.B.B.S.[2] Fatimo Biobaku M.B.B.S [3] Vamsikrishna Gunnam M.B.B.S [4]

Overview

Tricuspid stenosis (TS) is characterized by structural changes in the tricuspid valve. The pathophysiology of tricuspid valve depends on the underlying etiology. In rheumatic heart disease which is the most common cause of tricuspid stenosis, there is fibrous thickening of the valve leaflets and chordae tendineae with/without fusion of the commissures as a result of inflammation. The obstruction to right ventricular filling due to the stenotic tricuspid valve can result in systemic venous hypertension and congestion.

Pathophysiology

Pathogenesis

Normal surgical anatomy. (a) Superior view of the tricuspid valve shows the anterior leaflet (A), which is the largest; the septal leaflet (S), which is the smallest; and the posterior/inferior leaflet (P). (b) Another view of the tricuspid valve showing the papillary muscles, which are more numerous, smaller and more widely separated than those on the left side of the heart. Case courtesy by Soham Shah et al[8]


Associated Conditions

References

  1. Shah PM, Raney AA (February 2008). "Tricuspid valve disease". Curr Probl Cardiol. 33 (2): 47–84. doi:10.1016/j.cpcardiol.2007.10.004. PMID 18222317.
  2. [+https://www.sciencedirect.com/science/article/pii/B9780124202191000124?via%3Dihub "Valvular Heart Disease - ScienceDirect"] Check |url= value (help).
  3. Farag M, Arif R, Sabashnikov A, Zeriouh M, Popov AF, Ruhparwar A, Schmack B, Dohmen PM, Szabó G, Karck M, Weymann A (February 2017). "Repair or Replacement for Isolated Tricuspid Valve Pathology? Insights from a Surgical Analysis on Long-Term Survival". Med. Sci. Monit. 23: 1017–1025. doi:10.12659/msm.900841. PMC 5338566. PMID 28236633.
  4. Salem A, Abdelgawad A, Elshemy A (August 2018). "Early and Midterm Outcomes of Rheumatic Mitral Valve Repair". Heart Surg Forum. 21 (5): E352–E358. doi:10.1532/hsf.1978. PMID 30311884. Vancouver style error: initials (help)
  5. 5.0 5.1 5.2 Waller BF, Howard J, Fess S (1995). "Pathology of tricuspid valve stenosis and pure tricuspid regurgitation--Part I." Clin Cardiol. 18 (2): 97–102. PMID 7720297.
  6. Nishimura RA, Carabello BA (May 2012). "Hemodynamics in the cardiac catheterization laboratory of the 21st century". Circulation. 125 (17): 2138–50. doi:10.1161/CIRCULATIONAHA.111.060319. PMID 22547754.
  7. Hinton RB, Lincoln J, Deutsch GH, Osinska H, Manning PB, Benson DW, Yutzey KE (June 2006). "Extracellular matrix remodeling and organization in developing and diseased aortic valves". Circ. Res. 98 (11): 1431–8. doi:10.1161/01.RES.0000224114.65109.4e. PMID 16645142.
  8. "Multimodal imaging of the tricuspid valve: normal appearance and pathological entities".
  9. Mathur A, Sharma N, Goyal P, Mittal P (August 2019). "Surgical Algorithm for Rheumatic Tricuspid Disease". Ann. Thorac. Surg. 108 (2): e129–e132. doi:10.1016/j.athoracsur.2019.02.009. PMID 30885854.
  10. Itzhaki Ben Zadok O, Sagie A, Vaturi M, Shapira Y, Schwartzenberg S, Kuznitz I, Shochat T, Bental T, Yedidya I, Aravot D, Kornowski R, Sharony R (February 2019). "Long-Term Outcomes After Mitral Valve Replacement and Tricuspid Annuloplasty in Rheumatic Patients". Ann. Thorac. Surg. 107 (2): 539–545. doi:10.1016/j.athoracsur.2018.09.012. PMID 30617023.
  11. Waller BF, Howard J, Fess S (March 1995). "Pathology of tricuspid valve stenosis and pure tricuspid regurgitation--Part II". Clin Cardiol. 18 (3): 167–74. doi:10.1002/clc.4960180312. PMID 7743689.
  12. Hayes AR, Davar J, Caplin ME (September 2018). "Carcinoid Heart Disease: A Review". Endocrinol. Metab. Clin. North Am. 47 (3): 671–682. doi:10.1016/j.ecl.2018.04.012. PMID 30098723.
  13. Hassan SA, Banchs J, Iliescu C, Dasari A, Lopez-Mattei J, Yusuf SW (October 2017). "Carcinoid heart disease". Heart. 103 (19): 1488–1495. doi:10.1136/heartjnl-2017-311261. PMID 28596302.
  14. Perry D, Hayek SS (November 2019). "Carcinoid Heart Disease: A Guide for Clinicians". Cardiol Clin. 37 (4): 497–503. doi:10.1016/j.ccl.2019.07.014. PMID 31587790.
  15. Aboukhoudir F, Boulet V, Rekik S, Pansieri M (November 2017). "[Lead-related infective endocarditis with massive vegetation causing severe functionnal tricuspid stenosis]". Ann Cardiol Angeiol (Paris) (in French). 66 (5): 326–329. doi:10.1016/j.ancard.2017.09.012. PMID 29050737.

Template:WH

Template:WS